- Generic name
- Apixaban
- Strength
- 5 mg
- Dosage form
- Tablet
- Manufactured by
- Renata PLC.
Apilyte 5 Tablet
About Apilyte 5 Tablet
Apilyte 5 is a 5 mg tablet containing apixaban, an anticoagulant that reduces the blood's tendency to form harmful clots. It is prescribed for specific heart and vein conditions, and the dose is always set by a doctor.
There are 16 brands of Apixaban listed in Bangladesh. The lowest listed price is Antixa 2.5 mg Tablet at ৳ 10.00 per unit.
What is Apilyte 5 Tablet?
Apilyte 5 works by blocking one of the body's clotting proteins, factor Xa, which is needed for blood to clot. By slowing this step, the medicine lowers the chance of clots forming inside blood vessels. It comes as a 5 mg tablet from Renata PLC. It is used in selected conditions such as an irregular heartbeat called nonvalvular atrial fibrillation, after hip or knee replacement surgery, and in the treatment of deep vein thrombosis. Because it affects clotting, bleeding is the main concern, and it should only be taken under medical supervision.
Uses of Apilyte 5
Apilyte 5 is used to lower the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation. It is also used to help prevent deep vein thrombosis, which can lead to pulmonary embolism, in people who have had hip or knee replacement surgery. It is further used in the treatment of deep vein thrombosis. Whether it suits a particular person depends on their condition and history, so the doctor makes that decision.
How to use Apilyte 5
Take Apilyte 5 as your doctor tells you. The doctor decides the dose and how long you take it, including any change in dose for your age, weight, kidney function or other medicines. Swallow the tablet as advised. Do not stop it on your own, because stopping suddenly can raise the risk of clots and stroke. If you miss a dose, ask your doctor or pharmacist what to do rather than guessing.
Side effects of Apilyte 5
The main concern with Apilyte 5 is bleeding, because the medicine reduces the blood's clotting ability. A skin rash or a severe allergic reaction can also occur. Tell your doctor promptly about unusual or prolonged bleeding, or any rash or allergic symptoms. Your doctor or pharmacist can explain what warning signs to watch for and what to do if they appear.
Safety and precautions
Do not use Apilyte 5 if you have active pathological bleeding or have had a severe allergic reaction to apixaban. Stopping the medicine without another anticoagulant raises the risk of clots and stroke, so any stop must be planned with your doctor. It should not be used in pregnancy unless the doctor judges the benefit outweighs the risk, as it may increase bleeding during pregnancy and delivery. It is unknown whether it passes into breast milk, so breastfeeding mothers should ask their doctor. Tell your doctor about all other medicines you take.
Frequently asked questions
What does the 5 mg tablet form mean?
Apilyte 5 is a tablet, a solid form you swallow, and 5 mg is the amount of apixaban in each tablet. The doctor decides how much and how often you take it; the strength on the pack is not a dose instruction for you.
What is Apilyte 5 used for and what kind of medicine is it?
It is an anticoagulant containing apixaban. It is used to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, to help prevent deep vein thrombosis after hip or knee replacement surgery, and to treat deep vein thrombosis. Your doctor will confirm whether it is suitable for you.
Is it safe in pregnancy or breastfeeding?
There are no adequate studies of apixaban in pregnant women, and it may increase bleeding during pregnancy and delivery, so it is used in pregnancy only if the doctor judges the benefit outweighs the risk. It is unknown whether it passes into breast milk, so breastfeeding mothers should ask their doctor before use.
Can I stop taking it on my own?
No. Stopping apixaban without another anticoagulant raises the risk of clots and stroke. If it needs to be stopped for any reason other than bleeding, your doctor will plan another anticoagulant to cover you. Always speak to your doctor before making any change.
Indications
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery ... Read more
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- For the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery
- For the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy
Pharmacology
Dosage & Administration
Dosage Adjustments: The recommended dose of Apixaban is 2.5 mg twice daily in patients with any 2 of the following characteristics: age ≥80 years, body weight ≤60 kg, serum creatinine ≥1.5mg/dl.
CYP3A4 and P-gp inhibitors: When Apixaban is coadministered with drugs that are strong dual inhibitors of cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) (e.g. ketoconazole, itraconazole, ritonavir, clarithromycin) the recommended dose is 2.5 mg twice daily.
Missed Dose: If a dose of Apixaban is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-daily administration should be resumed. The dose should not be doubled to make up for a missed dose.
Discontinuation for Surgery and Other Interventions: Apixaban should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding. Apixaban should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where the bleeding would be non-critical in location and easily controlled.
Switching from or to Apixaban: Switching from warfarin to Apixaban: Warfarin should be discontinued and Apixaban started when the international normalized ratio (INR) is below 2.0.
Switching from Apixaban to warfarin: Apixaban affects INR, so that INR measurements during co-administration with warfarin may not be useful for determining the appropriate dose of warfarin. If continuous anticoagulation is necessary, discontinue Apixaban and begin both a parenteral anticoagulant and warfarin at the time the next dose of Apixaban would have been taken, discontinuing the parenteral anticoagulant when INR reaches an acceptable range.
Switching between Apixaban and anticoagulants other than warfarin: Discontinue one being taken and begin the other at the next scheduled dose.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Labor and Delivery: Safety and effectiveness of Apixaban during labor and delivery have not been studied in clinical trials. Consider the risks of bleeding and of stroke in using Apixaban in this condition.
Nursing Mothers: It is unknown whether Apixaban or its metabolites are excreted in human milk. Women should be instructed either to discontinue breastfeeding or to discontinue Apixaban therapy, taking into account the importance of the drug to the mother.
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Apixaban
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.